The role of SREBP-1c signaling pathway in osteoblast pyroptosis and the protective effect of D-pinitol
Preclinical animal studies and human trials have indicated that D-pinitol may have multiple beneficial properties, such as regulating lipid metabolism and anti-osteoporosis. The purpose of this research was to use in vivo and in vitro methods to explore lipid-induced pyroptosis in osteogenic differentiation and osteoporosis development, while also examining DP's regulatory role in preventing osteoblast pyroptosis. Results demonstrated that daily oral administration of D-pinitol (DP) at a clinically relevant dose significantly ameliorated bone microarchitecture deterioration in apolipoprotein A1-deficient (ApoA1 −/− ) mice. DP increased Runx2 and OST expressions, and enhanced the bone-mineralized nodules production in ox-LDL-treated MC3T3-E1 cells. DP also lowered pyroptosis-related indicators such as NLRP3, Caspase-1, GSDMD, GSDMD N-terminal (GSDMD-NT), Cleaved caspase-1, and IL-1β. Mechanistically, we found that DP inhibited NLRP3-mediated pyroptosis by downregulating SREBP-1c and altering p53 and Galectin-1 signaling. Our findings indicated that SREBP-1c is involved in lipid metabolism disorder-induced activation of the NLRP3 and ultimately results in osteogenic pyroptosis. DP could inhibit the SREBP-1c pathway to protect osteoblasts, thereby ameliorating osteoporosis. Diagrammatic illustration of the working model showing how the DP inhibits the SREBP-1c signaling pathway to reduce osteoblast pyroptosis caused by lipid dysmetabolism. • DP administration inhibits bone pyroptosis and rescued bone loss in ApoA1−/− mice. • Ox-LDL-induced lipid accumulation caused osteoblasts to undergo pyroptotic cell death via SREBP-1 activation. • Treatment with DP markedly attenuated ox-LDL mediated the inhibition of bone formation and osteogenic pyroptosis. • DP inhibited the SREBP-1c pathway via altering its downstream signaling pathways, such as p-p53 and Galectin-1 to protect osteoblasts from lipid metabolic dysfunction-induced pyroptosis thereby ameliorating osteoporosis.
Authors
- Haiqing Gao (ORCID: https://orcid.org/0000-0003-2230-0576)
- Baoying Li (ORCID: https://orcid.org/0000-0002-5845-0720)
- Chaochao Dai
- Xue Chao Wang (ORCID: https://orcid.org/0000-0002-2381-9145)
- Jie Wang (ORCID: https://orcid.org/0000-0002-7223-8742)
- Yajuan Wang (ORCID: https://orcid.org/0000-0002-3284-9012)
- Wenqian Zhao (ORCID: https://orcid.org/0009-0008-3308-9837)
- Fang Li (ORCID: https://orcid.org/0000-0002-7968-3208)
- Mei Cheng
Institutions
- Jinan Central Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Journal of Functional Foods
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1016/j.jff.2025.106846
- Citations
- 1
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.81